DK3433241T3 - Fremgangsmåde til fremstilling af epoprostenol-natrium med forbedret stabilitet - Google Patents

Fremgangsmåde til fremstilling af epoprostenol-natrium med forbedret stabilitet Download PDF

Info

Publication number
DK3433241T3
DK3433241T3 DK17712755.2T DK17712755T DK3433241T3 DK 3433241 T3 DK3433241 T3 DK 3433241T3 DK 17712755 T DK17712755 T DK 17712755T DK 3433241 T3 DK3433241 T3 DK 3433241T3
Authority
DK
Denmark
Prior art keywords
preparing
procedure
improved stability
epoprostenol sodium
epoprostenol
Prior art date
Application number
DK17712755.2T
Other languages
English (en)
Inventor
Irén Hortobágyi
Zsuzsanna Kardos
István Lászlófi
József Molnár
László Takács
Róbertné Tormási
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of DK3433241T3 publication Critical patent/DK3433241T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK17712755.2T 2016-03-23 2017-03-21 Fremgangsmåde til fremstilling af epoprostenol-natrium med forbedret stabilitet DK3433241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1600211A HU231031B1 (hu) 2016-03-23 2016-03-23 Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
PCT/EP2017/056690 WO2017162668A1 (en) 2016-03-23 2017-03-21 Process for the preparation of epoprostenol sodium of enhanced stability

Publications (1)

Publication Number Publication Date
DK3433241T3 true DK3433241T3 (da) 2021-02-15

Family

ID=89992124

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17712755.2T DK3433241T3 (da) 2016-03-23 2017-03-21 Fremgangsmåde til fremstilling af epoprostenol-natrium med forbedret stabilitet

Country Status (12)

Country Link
US (1) US10981884B2 (da)
EP (1) EP3433241B1 (da)
JP (1) JP6871942B2 (da)
KR (1) KR102376668B1 (da)
CN (1) CN109153660B (da)
CY (1) CY1123966T1 (da)
DK (1) DK3433241T3 (da)
ES (1) ES2853699T3 (da)
HU (2) HU231031B1 (da)
RU (1) RU2747646C2 (da)
TW (1) TWI738746B (da)
WO (1) WO2017162668A1 (da)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583961A (en) 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
ZA787353B (en) 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
RU2423130C2 (ru) * 2006-02-03 2011-07-10 Актелион Уан Са Композиция, содержащая эпопростенол, и способ ее получения
CA2641393C (en) 2006-02-03 2014-12-16 Scidose Llc Novel epoprostenol formulation and method of making thereof
CN103585119A (zh) * 2013-11-13 2014-02-19 北京泰德制药股份有限公司 一种包含依前列醇及其药用盐的稳定化制剂及其制备方法

Also Published As

Publication number Publication date
TWI738746B (zh) 2021-09-11
WO2017162668A1 (en) 2017-09-28
CN109153660A (zh) 2019-01-04
HUE053193T2 (hu) 2021-06-28
JP6871942B2 (ja) 2021-05-19
TW201808303A (zh) 2018-03-16
CY1123966T1 (el) 2022-05-27
US10981884B2 (en) 2021-04-20
KR20180127426A (ko) 2018-11-28
HUP1600211A2 (en) 2017-09-28
RU2018136065A3 (da) 2020-06-01
HU231031B1 (hu) 2019-12-30
JP2019510765A (ja) 2019-04-18
ES2853699T3 (es) 2021-09-17
EP3433241A1 (en) 2019-01-30
RU2018136065A (ru) 2020-04-23
CN109153660B (zh) 2022-10-11
EP3433241B1 (en) 2020-11-25
RU2747646C2 (ru) 2021-05-11
KR102376668B1 (ko) 2022-03-21
US20200123124A1 (en) 2020-04-23

Similar Documents

Publication Publication Date Title
DK3359318T3 (da) Fremgangsmåde til 3d-printning under anvendelse af en suspension
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3083540T3 (da) Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3372584T5 (da) Fremgangsmåde til fremstillingen af en diarylthiohydantoin-forbindelse
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3398378T3 (da) Fremgangsmåde til oprettelse af en roaming-forbindelse
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3383436T3 (da) Forbedret fremgangsmåde til fremstilling af indocyaningrønt
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3105220T3 (da) Fremgangsmåde til fremstilling af pyrimidinsulfamidderivater
DK3081637T3 (da) Fremgangsmåde til fremstilling af en ciliær marginalzonelignende struktur
DK3376923T3 (da) Fremgangsmåde til tilberedning af en drik
DK3369724T3 (da) Fremgangsmåde til fremstilling af iopamidol
DK3152191T3 (da) Forbedret fremgangsmåde til fremstilling af duocarmycin-prodrugs
DK3274143T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3116854T3 (da) Ny fremgangsmåde til fremstilling af prostaglandiner med høj renhed
DK3137449T3 (da) Fremgangsmåder til fremstilling af substituerede cycloseriner
DK3302788T3 (da) Fremgangsmåde til fremstilling af en sorbent
DK3250523T3 (da) Fremgangsmåde til fremstillingen af en silikasmeltemasse
DK3507282T3 (da) Fremgangsmåde til fremstilling af indolcarboxamidforbindelser
DK3431590T3 (da) Fremgangsmåde til fremstilling af aktiveret hepatocytvækstfaktor (hgf)